-
1دورية أكاديمية
المؤلفون: Baron F., Nagler A., Galimard J. -E., Sanz J., Versluis J., Forcade E., Chevallier P., Sirvent A., Anthias C., Kuball J., Furst S., Rambaldi A., Sierra J., von dem Borne P. A., GallegoHernanz M. P., Cluzeau T., Robinson S., Raiola A. M., Labussiere-Wallet H., Byrne J. L., Malfuson J. -V., Ruggeri A., Mohty M., Ciceri F.
المساهمون: Baron, F., Nagler, A., Galimard, J. -E., Sanz, J., Versluis, J., Forcade, E., Chevallier, P., Sirvent, A., Anthias, C., Kuball, J., Furst, S., Rambaldi, A., Sierra, J., von dem Borne, P. A., Gallegohernanz, M. P., Cluzeau, T., Robinson, S., Raiola, A. M., Labussiere-Wallet, H., Byrne, J. L., Malfuson, J. -V., Ruggeri, A., Mohty, M., Ciceri, F.
مصطلحات موضوعية: acute myeloid leukaemia, AML, cord blood transplantation, de novo, secondary
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001075255800001; volume:204; issue:1; firstpage:250; lastpage:259; numberofpages:10; journal:BRITISH JOURNAL OF HAEMATOLOGY; https://hdl.handle.net/20.500.11768/165016Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85173459626
الإتاحة: https://doi.org/20.500.11768/16501610.1111/bjh.19130Test
https://hdl.handle.net/20.500.11768/165016Test -
2دورية أكاديمية
المؤلفون: Jeroen Janssen, Bob Löwenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, Anna Efthymiou, Bjørn-Tore Gjertsen, Carlos Graux, Michael Gregor, Dominik Heim, Urs Hess, Mels Hoogendoorn, Aurelie Jaspers, Asiong Jie, Mojca Jongen-Lavrencic, Saskia Klein, Marjolein van der Klift, Jürgen Kuball, Danielle van Lammeren-Venema, Marie-Cecile Legdeur, Arjan van de Loosdrecht, Johan Maertens, Marinus van Marwijk Kooy, Ine Moors, Marten Nijziel, Florence van Obbergh, Margriet Oosterveld, Thomas Pabst, Marjolein van der Poel, Harm Sinnige, Olivier Spertini, Wim Terpstra, Lidwine Tick, Walter van der Velden, Marie-Christiane Vekemans, Edo Vellenga, Okke de Weerdt, Peter Westerweel, Georg Stüssi, Yvette van Norden, Gert Ossenkoppele
المصدر: Cancers, Vol 13, Iss 4, p 672 (2021)
مصطلحات موضوعية: AML, high-risk MDS, tosedostat, clinical trial, aminopeptidase inhibitor, elderly, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource